Private Equity
Marblehead, Massachusetts-based Allievex Corporation, a biotechnology company, has secured an undisclosed amount of Series A financing. Novo Holdings and Pappas Capital led the round. In addition to the funding, Allievex has named Dr. Kyle Rasbach, a managing partner at Pappas Ventures and Dr. Tiba Aynechi, a partner at Novo Holdings, to its board of directors.
1 min read · 23 October 2019
2 min read · 23 October 2019
Maze Therapeutics, a company focused on translating genetic insights into new medicines, has secured funding from City Hill Ventures. No financial terms were disclosed. In addition to the funding, Dr. Jonathan Lim, founder and managing partner at City Hill, has joined the Maze board of directors.
1 min read · 23 October 2019
Berkeley, California-based Medinas, a technology-driven asset management company for hospitals, has raised $5 million in seed funding. NFX led the round with participation from other investors that included Precursor Ventures, Sound Ventures, FJ Labs and Bryan Frist.
1 min read · 22 October 2019
San Diego-based Intrepida Bio Inc, a newly launched drug developer, has secured $9.5 million in funding. The investors were Sofinnova Investments and Canaan.
1 min read · 22 October 2019
Catalyst Health Ventures has raised $60.5 million for its fourth fund, according to an SEC filing. The target was $100 million. Based in Braintree, Massachusetts, Catalyst Health Ventures targets tech solutions in the healthcare and life science industries.
1 min read · 22 October 2019
Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
1 min read · 22 October 2019
2 min read · 21 October 2019
1 min read · 21 October 2019
2 min read · 21 October 2019
